search
Back to results

Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)

Primary Purpose

Dehydration, Acute Gastroenteritis

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard IV Rehydration Therapy
Oral Rehydration Therapy (ORT)
Sponsored by
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dehydration focused on measuring vomiting, diarrhea

Eligibility Criteria

6 Months - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 6 mths to 18 years;
  • Signs and symptoms of dehydration for less than a week
  • Diagnosis of acute gastroenteritis, dehydration, vomiting, and/or diarrhea;
  • Patient able to drink from bottle and/or cup;
  • Per clinician's judgment, patient needs rehydration with IV solution.

Exclusion Criteria:

  • Chronic disease that includes but not limited to TB, HIV, congenital heart disease with hemodynamic consequences, metabolic disease, cerebral palsy, adrenal hyperplasia, renal tubular acidosis, and nephropathy;
  • Vomiting due to head trauma;
  • Severe hydration;
  • Diabetic ketoacidosis;
  • Bloody diarrhea;
  • Diarrhea for more than a week;
  • Malnutrition;
  • Burns;
  • Pneumonia;
  • Meningitis;
  • History of seizures;
  • Absent bowel sounds;
  • Not able to drink from bottle or cup;
  • Previous allergic reaction to citrate or other food coloring particles/formulation;
  • Parent/legal guardian refusing to participate.

Sites / Locations

  • Nicklaus Children's Hospital f/k/a Miami Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard IV Rehydration Therapy

Oral Rehydration Therapy (ORT)

Arm Description

Patients randomized into the IV rehydration group will receive a Normal Saline bolus of IVF (usually 20 mL/kg) which is the standard therapy up to 24 hrs or as needed depending on patient's weight

Patients randomized into the oral rehydration group will receive the oral Speedlyte product instead of the IV rehydration therapy.

Outcomes

Primary Outcome Measures

Length of stay (LOS)
Comparison of length of stay (LOS) in a pediatric emergency department in the treatment of acute gastroenteritis between the oral rehydration solution Speedlyte and intravenous rehydration.

Secondary Outcome Measures

Adjunct Medication
Number of adjunct medications given in the ED in both groups

Full Information

First Posted
April 19, 2018
Last Updated
January 22, 2020
Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Collaborators
Einsoff Biohealth
search

1. Study Identification

Unique Protocol Identification Number
NCT03562702
Brief Title
Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)
Official Title
Comparative Study Between the Oral Rehydration Product, Speedlyte, With Lipophilic Absorption and IV Rehydration in Treatment of Children With Gastroenteritis in a Pediatric Emergency Department
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Terminated
Why Stopped
Access to Speedlyte Product no longer available.
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
January 22, 2020 (Actual)
Study Completion Date
January 22, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Collaborators
Einsoff Biohealth

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare length of stay (LOS) of pediatric patients in a pediatric emergency room presenting with Gastroenteritis treated with IV rehydration versus oral Speedlyte rehydration.
Detailed Description
Gastroenteritis leading to dehydration is very commonly encountered in the pediatric emergency room setting. Oral rehydration therapy (ORT) is the first line therapy recommended by the American Academy of Pediatrics but is seldom used compared to intravenous therapy (IVT). ORT has many advantages including less traumatic to the patient, can be administered by mouth, can be administered at home and less costly compared to IVT. Furthermore, intravenous fluids may present several complications with IV placement such as infiltration, hematoma, air embolism, phlebitis, extravascular injection, intraarterial injection, etc. Speedlyte is a new oral rehydration product with lipophilic absorption which allows for electrolytes to be more readily absorbed compared to other oral rehydration solutions. The liposome encapsulates the salty molecules which is thought to decrease the negative salty taste associated with oral rehydration solutions. In addition, the encapsulation of electrolytes allows for more molecules to be delivered past the stomach acids and absorbed into the body under higher bioavailability due to the lipid shell. Participants will be randomized into two rehydration groups. One group will receive oral rehydration with the Speedlyte product, the amount will be based on the participant's weight. The other group will receive intravenous rehydration with a normal saline bolus per physician practice, usually in the amount of 20 mL/kg. These interventions can be incorporated into the emergency room practice without undue expense to the setting or placing excessive demands on nursing time as these practices are standard of care in many rehydration cases.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dehydration, Acute Gastroenteritis
Keywords
vomiting, diarrhea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Masking Description
The assignment of treatment will be concealed from research team members involved in recruiting patients by using sealed, sequentially numbered, opaque envelopes containing the type of rehydration treatment to be used.
Allocation
Randomized
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard IV Rehydration Therapy
Arm Type
Active Comparator
Arm Description
Patients randomized into the IV rehydration group will receive a Normal Saline bolus of IVF (usually 20 mL/kg) which is the standard therapy up to 24 hrs or as needed depending on patient's weight
Arm Title
Oral Rehydration Therapy (ORT)
Arm Type
Experimental
Arm Description
Patients randomized into the oral rehydration group will receive the oral Speedlyte product instead of the IV rehydration therapy.
Intervention Type
Other
Intervention Name(s)
Standard IV Rehydration Therapy
Intervention Description
IV rehydration group receiving a Normal Saline bolus of IVF (usually 20 ml/kg)
Intervention Type
Other
Intervention Name(s)
Oral Rehydration Therapy (ORT)
Intervention Description
Speedlyte oral solution as rehydration therapy based on participant's weight (10 m/l kg over one hour). Total of 150 ml/kg over 24 hours prior to discharge
Primary Outcome Measure Information:
Title
Length of stay (LOS)
Description
Comparison of length of stay (LOS) in a pediatric emergency department in the treatment of acute gastroenteritis between the oral rehydration solution Speedlyte and intravenous rehydration.
Time Frame
up to 24 hours
Secondary Outcome Measure Information:
Title
Adjunct Medication
Description
Number of adjunct medications given in the ED in both groups
Time Frame
up to 24 hours
Other Pre-specified Outcome Measures:
Title
Time to initiation of therapy
Description
Time to initiation of therapy in each group
Time Frame
up to 24 hours
Title
Number of patients that fail to rehydrate
Description
Obtain the number of patients that fail to rehydrate in each group. Oral requiring IV intervention, IV requiring further fluids and/or admission.
Time Frame
up to 24 hours
Title
Hospitalization rate
Description
The rate of hospitalization for each group
Time Frame
up to 24 hours
Title
Revisit rate in each group.
Description
The revisit rate for each group
Time Frame
up to 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 6 mths to 18 years; Signs and symptoms of dehydration for less than a week Diagnosis of acute gastroenteritis, dehydration, vomiting, and/or diarrhea; Patient able to drink from bottle and/or cup; Per clinician's judgment, patient needs rehydration with IV solution. Exclusion Criteria: Chronic disease that includes but not limited to TB, HIV, congenital heart disease with hemodynamic consequences, metabolic disease, cerebral palsy, adrenal hyperplasia, renal tubular acidosis, and nephropathy; Vomiting due to head trauma; Severe hydration; Diabetic ketoacidosis; Bloody diarrhea; Diarrhea for more than a week; Malnutrition; Burns; Pneumonia; Meningitis; History of seizures; Absent bowel sounds; Not able to drink from bottle or cup; Previous allergic reaction to citrate or other food coloring particles/formulation; Parent/legal guardian refusing to participate.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Barbara Pena, MD
Organizational Affiliation
Nicklaus Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
15086953
Citation
Bellemare S, Hartling L, Wiebe N, Russell K, Craig WR, McConnell D, Klassen TP. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med. 2004 Apr 15;2:11. doi: 10.1186/1741-7015-2-11.
Results Reference
background
PubMed Identifier
15687435
Citation
Spandorfer PR, Alessandrini EA, Joffe MD, Localio R, Shaw KN. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics. 2005 Feb;115(2):295-301. doi: 10.1542/peds.2004-0245.
Results Reference
background

Learn more about this trial

Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)

We'll reach out to this number within 24 hrs